Literature DB >> 24337374

Killer Ig-like receptor 2DL4 does not mediate NK cell IFN-γ responses to soluble HLA-G preparations.

Michael E L Le Page1, Jodie P Goodridge, Elisabeth John, Frank T Christiansen, Campbell S Witt.   

Abstract

The MHC class Ib molecule HLA-G has previously been reported to be the ligand for the NK cell receptor killer Ig-like receptor (KIR)2DL4, but this remains controversial. In this study, we investigated IFN-γ production by freshly isolated NK cells in response to both soluble and solid-phase ligands, including anti-KIR2DL4 mAbs and rHLA-G. Although freshly isolated CD56(bright) NK cells produced IFN-γ in response to soluble HLA-G preparations, the response was found to be absolutely dependent on the presence of small numbers of contaminating CD56(-), CD14(-), CD11c(+) myeloid dendritic cells (mDCs). HLA-G tetramers bound only to the contaminating mDCs in the NK preparations, and Abs to KIR2DL4 and HLA-G did not block NK cell IFN-γ production. NK cells did not respond to plate-bound HLA-G. Freshly isolated NK cells also produced IFN-γ in response to unpurified soluble anti-KIR2DL4 mAb but not to low endotoxin affinity-purified Ab. The data suggest that previous reports of functional interactions between KIR2DL4 and HLA-G may have resulted from the use of purified NK cells that were contaminated with mDCs and HLA-G preparations that were contaminated with material capable of stimulating mDCs to produce cytokines that stimulate NK cells to produce IFN-γ.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24337374     DOI: 10.4049/jimmunol.1301748

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  KIR and HLA under pressure: evidences of coevolution across worldwide populations.

Authors:  Danillo G Augusto; Maria Luiza Petzl-Erler
Journal:  Hum Genet       Date:  2015-06-23       Impact factor: 4.132

2.  The structure of the atypical killer cell immunoglobulin-like receptor, KIR2DL4.

Authors:  Shoeib Moradi; Richard Berry; Phillip Pymm; Corinne Hitchen; Simone A Beckham; Matthew C J Wilce; Nicholas G Walpole; Craig S Clements; Hugh H Reid; Matthew A Perugini; Andrew G Brooks; Jamie Rossjohn; Julian P Vivian
Journal:  J Biol Chem       Date:  2015-03-10       Impact factor: 5.157

3.  Human Parthenogenetic Embryonic Stem Cell-Derived Neural Stem Cells Express HLA-G and Show Unique Resistance to NK Cell-Mediated Killing.

Authors:  Jessica Schmitt; Sigrid Eckardt; Paul G Schlegel; Anna-Leena Sirén; Valentin S Bruttel; K John McLaughlin; Jörg Wischhusen; Albrecht M Müller
Journal:  Mol Med       Date:  2015-03-23       Impact factor: 6.354

Review 4.  Why is placentation abnormal in preeclampsia?

Authors:  Susan J Fisher
Journal:  Am J Obstet Gynecol       Date:  2015-10       Impact factor: 8.661

5.  The Autoimmune Regulator (Aire) transactivates HLA-G gene expression in thymic epithelial cells.

Authors:  Breno Luiz Melo-Lima; Isabelle Poras; Geraldo Aleixo Passos; Edgardo D Carosella; Eduardo Antonio Donadi; Philippe Moreau
Journal:  Immunology       Date:  2019-08-19       Impact factor: 7.397

6.  Comment on "Killer Ig-like receptor 2DL4 does not mediate NK Cell IFN-γ responses to soluble HLA-G preparations".

Authors:  Sumati Rajagopalan; Eric O Long
Journal:  J Immunol       Date:  2014-05-01       Impact factor: 5.422

Review 7.  Immunomodulating functions of human leukocyte antigen-G and its role in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Authors:  Xiaoyin Bu; Jinman Zhong; Weiru Li; Shengchun Cai; Ya Gao; Baohong Ping
Journal:  Ann Hematol       Date:  2021-03-11       Impact factor: 3.673

Review 8.  Controlling the Immunological Crosstalk during Conception and Pregnancy: HLA-G in Reproduction.

Authors:  Line Lynge Nilsson; Snezana Djurisic; Thomas Vauvert F Hviid
Journal:  Front Immunol       Date:  2014-05-13       Impact factor: 7.561

9.  Two new cases of KIR3DP1, KIR2DL4-negative genotypes, one of which is also lacking KIR3DL2.

Authors:  Wanda Niepiekło-Miniewska; Natalia Zuk; Joanna Dubis; Maciej Kurpisz; David Senitzer; Anna Havrylyuk; Ryszard Grendziak; Wojciech Witkiewicz; Valentyna Chopyak; Piotr Kuśnierczyk
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-07-18       Impact factor: 4.291

10.  Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab.

Authors:  Guoxu Zheng; Zhangyan Guo; Weimiao Li; Wenjin Xi; Baile Zuo; Rui Zhang; Weihong Wen; An-Gang Yang; Lintao Jia
Journal:  Signal Transduct Target Ther       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.